Clinical Trials on Multiple Myeloma(MM) in Finland
Total 313 results
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Non-Hodgkin Lymphoma (NHL)Belgium, Italy, Korea, Republic of, Hong Kong, Israel, Finland, Spain, Japan, United States
-
AbbVieTerminatedCancer | Multiple Myeloma (MM)United States, Australia, France, Israel, Japan, Spain, Taiwan
-
Raija SilvennoinenBristol-Myers Squibb; Amgen; Hospital District of Helsinki and UusimaaCompletedMultiple Myeloma in RelapseFinland, Sweden
-
Alliance Foundation Trials, LLC.Pharmacyclics LLC.Active, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Helsinki University Central HospitalRecruitingMedial Epicondyle Fracture of the Humerus | 7 to16 Year Old Children and Adolecents | More Than 2 mm of DisplacementFinland
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaboratorsCompleted
-
Turku University HospitalActive, not recruitingMultiple SclerosisFinland
-
National Cancer Institute (NCI)Active, not recruitingDS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States, Saudi Arabia, Puerto Rico
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia (AML)Finland
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFinland
-
Stichting European Myeloma NetworkPfizerRecruitingSmoldering Multiple MyelomaNetherlands, France, Italy, Finland, Greece, Norway
-
Turku University HospitalCompletedMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingFinland
-
Indapta Therapeutics, INC.RecruitingMultiple Myeloma | Refractory Multiple Myeloma | Refractory Non-Hodgkin Lymphoma | NHL | Blood Cancer | Relapsed Multiple Myeloma | Relapsed Non-Hodgkin LymphomaUnited States
-
Helsinki University Central HospitalActive, not recruiting
-
Nordic Myeloma Study GroupJanssen-Cilag Ltd.CompletedMultiple MyelomaNorway, Sweden, Denmark, Finland, Iceland
-
Henrik GregersenNordic Myeloma Study GroupUnknownMultiple MyelomaFinland, Denmark, Sweden, Norway, Lithuania
-
SanofiRecruitingPlasma Cell MyelomaCzechia, Australia, Chile, France, Spain, United States, Brazil, China, Greece, Japan, Korea, Republic of, Sweden, Taiwan, Finland, Italy, Russian Federation
-
Raija SilvennoinenTakeda; Celgene; Nordic Myeloma Study GroupActive, not recruitingMultiple MyelomaNorway, Sweden, Finland, Lithuania
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
Turku University HospitalEnrolling by invitationMelanoma | Acute Myeloid Leukemia | Non Small Cell Lung CancerFinland
-
AmgenTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Turku University HospitalActive, not recruitingMultiple SclerosisFinland
-
Adam OlszewskiActive, not recruitingLymphoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Leukemia | Hematologic Malignancy | MyelomaUnited States
-
BayerBiogen Netherlands B.V; Novartis Europharm Limited; Merck Europe B.V.Not yet recruitingMultiple Sclerosis (MS)Sweden, Finland
-
Kuopio University HospitalCompletedRelapse-remitting Multiple SclerosisFinland
-
Kuopio University HospitalTurku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaboratorsCompleted
-
Turku University HospitalActive, not recruiting
-
University of Eastern FinlandCompletedQuality of Life | Fatigue | Physical Activity | Relapsing Remitting Multiple SclerosisFinland
-
Tampere UniversitySuspended
-
Turku University HospitalRecruiting
-
John L. ReaganThe Miriam Hospital; Rhode Island Hospital; Memorial Hospital of Rhode IslandActive, not recruiting
-
Turku University HospitalEnrolling by invitationMultiple SclerosisFinland
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada, United States
-
Joint Authority for Päijät-Häme Social and Health...CompletedMultiple Actinic KeratosesFinland
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); European Organisation for Research and Treatment... and other collaboratorsCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States, Canada
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada, United States
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaFrance, Czechia, Sweden, United States, Greece, Spain, Finland, Romania, Germany, Japan, Netherlands, Turkey, Austria, Bulgaria, Lithuania, Russian Federation, Slovakia
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States, Puerto Rico
-
Turku University HospitalCompletedMultiple SclerosisFinland
-
University of TurkuUnknownColecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)Multiple SclerosisFinland
-
CelgeneRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Australia, Italy, China, Spain, Germany, Romania, Korea, Republic of, Japan, United Kingdom, Czechia, Finland, France, Greece, Argentina, Belgium, Austria, Portugal, Israel, Poland, Brazil, Turkey, Canada, Ireland, New Zealand and more
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
MendusAmsterdam UMC, location VUmcActive, not recruitingAcute Myeloid Leukemia in RemissionNorway, Netherlands, Sweden, Finland, Germany
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | RISS Stage I Plasma Cell Myeloma | RISS Stage II Plasma Cell MyelomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Recruiting
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
BayerNovartis Pharmaceuticals; Biogen; EPID Research; Merck Serono Europe LtdCompleted
-
Amsterdam UMC, location VUmcMerck Sharp & Dohme LLC; Novartis; Uppsala University HospitalTerminatedChronic Myeloid LeukemiaNetherlands, Denmark, Sweden, Finland, Norway
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Light Chain Deposition DiseaseUnited States, Puerto Rico, Ireland